Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Comprehensive analyses with radiological and biological markers of breast cancer on contrast-enhanced chest CT: a single center experience using dual-layer spectral detector CT
Ist Teil von
European radiology, 2020-05, Vol.30 (5), p.2782-2790
Ort / Verlag
Berlin/Heidelberg: Springer Berlin Heidelberg
Erscheinungsjahr
2020
Quelle
MEDLINE
Beschreibungen/Notizen
Objectives
To evaluate the predictive value of virtual monoenergetic images (VMIs) by assessing tumor conspicuity on dual-layer spectral detector CT (SDCT) and correlate tumor conspicuity on VMI with prognostic biomarkers in patients with breast cancer.
Methods
Sixty-four patients underwent arterial phase and 90-s delayed phase dual-layer SDCT. A retrospective tumor conspicuity analysis of 14 benign tumors and 65 breast cancers was performed using conventional images (CIs) and VMI at 40 keV (VMI40) on arterial and delayed phase scans (CI
ART
, VMI40
ART
, CI
DE
, VMI40
DE
). Mean Hounsfield units (HU) of tumors were measured on VMI40
ART
and VMI40
DE
. A receiver operating characteristic (ROC) curve analysis was performed to compare diagnostic accuracy between image sets. Estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki67 levels were evaluated using histopathology. Correlations between VMI analyses and histological characteristics of cancers were analyzed.
Results
Cancers on VMI40 had a significantly higher conspicuity score and mean HU than benign tumors (
p
< 0.001). VMI40
DE
showed the highest conspicuity for cancers (mean, 3.79) and the greatest area under the ROC curve (0.817; 95% confidence interval 0.745–0.889). VMI40
DE
yielded significantly higher mean HU for cancers than VMI40
ART
(
p
< 0.001). The conspicuity score and mean HU on VMI40
ART
were significantly higher in cancers with ER negativity, PR negativity, and Ki67 positivity (
p
< 0.05).
Conclusions
VMI40
DE
may be useful in the diagnosis of breast cancers due to higher tumor conspicuity and better enhancement than VMI40
ART
. VMI40
ART
may be beneficial for the prediction of poor breast cancer prognoses.
Key Points
•
VMI40 improved conspicuity of breast cancer than CI.
•
VMI40
DE
yielded higher diagnostic performance of breast cancer than VMI40
ART
.
•
VMI40
ART
has an additional benefit in terms of prognosis prediction in patients with breast cancers.